Clinical Trial Update: Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases [NA]

View source ↗

Summary

A clinical trial evaluating the efficacy of umbilical cord blood mononuclear cells (UCB-MNCs) for refractory neonatal diseases, including hypoxic-ischemic encep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Hypoxic-ischemic Encephalopathy
• Short Bowel Syndrome

Drugs mentioned

• Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) (Umbilical Cord Blood Mononuclear Cells)

Snippet

Sponsor: Shandong Qilu Stem Cells Engineering Co., Ltd. | Conditions: Hypoxic-Ischemic Encephalopathy, Bronchopulmonary Dysplasia | NA | Status: RECRUITING